- Home
- GILD vs BA Comparison
GILD vs BA Comparison
Compare GILD & BA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GILD | BA |
|---|---|---|
| Founded | 1987 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.9B | 183.0B |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | GILD | BA |
|---|---|---|
| Price | $154.98 | $242.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 19 |
| Target Price | $141.56 | ★ $252.00 |
| AVG Volume (30 Days) | ★ 8.8M | 7.9M |
| Earning Date | 02-10-2026 | 01-27-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ 1684.21 | N/A |
| EPS | ★ 6.78 | 2.48 |
| Revenue | $29,443,000,000.00 | ★ $89,463,000,000.00 |
| Revenue This Year | $4.68 | $11.31 |
| Revenue Next Year | $5.11 | $14.90 |
| P/E Ratio | ★ $22.86 | $97.97 |
| Revenue Growth | 2.40 | ★ 34.50 |
| 52 Week Low | $93.37 | $128.88 |
| 52 Week High | $157.29 | $254.35 |
Technical Indicators
Market Signals| Indicator | GILD | BA |
|---|---|---|
| Relative Strength Index (RSI) | 70.71 | 57.97 |
| Support Level | $147.00 | $235.50 |
| Resistance Level | $157.29 | $247.86 |
| Average True Range (ATR) | 4.28 | 8.12 |
| MACD | 0.86 | -1.02 |
| Stochastic Oscillator | 88.30 | 55.14 |
Price Performance
Historical ComparisonAbout GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About BA Boeing Company (The)
Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.